Comment on "Meropenem, Cefepime, and Piperacillin Protein Binding in Patient Samples"

Affiliations

¹ Department of Pharmacotherapy and Translational Research, Infectious Disease Pharmacokinetics Lab, College of Pharmacy and Emerging Pathogens Institute, University of Florida, Gainesville, Florida.
² Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha, Saudi Arabia.

Comment

Mohammad H Al-Shaer et al. Ther Drug Monit. 2020 Dec.

. 2020 Dec;42(6):910.

doi: 10.1097/FTD.0000000000000810.

¹ Department of Pharmacotherapy and Translational Research, Infectious Disease Pharmacokinetics Lab, College of Pharmacy and Emerging Pathogens Institute, University of Florida, Gainesville, Florida.
² Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha, Saudi Arabia.

No abstract available

Comment on

Meropenem, Cefepime, and Piperacillin Protein Binding in Patient Samples.
Al-Shaer MH, Alghamdi WA, Graham E, Peloquin CA. Al-Shaer MH, et al. Ther Drug Monit. 2020 Feb;42(1):129-132. doi: 10.1097/FTD.0000000000000675. Ther Drug Monit. 2020. PMID: 31318843
Comment on "Meropenem, Cefepime, and Piperacillin Protein Binding in Patient Samples".
Liebchen U, Dorn C, Kees M, Schiesser S, Hitzenbichler F, Kees F, Paal M. Liebchen U, et al. Ther Drug Monit. 2020 Dec;42(6):909-910. doi: 10.1097/FTD.0000000000000809. Ther Drug Monit. 2020. PMID: 33186336 No abstract available.

1. Liebchen U, Dorn C, Kees M, et al. Comment on “meropenem, cefepime, and piperacillin protein binding in patient samples”. Ther Drug Monit. 2020;42:909–910.
1. Schleibinger M, Steinbach CL, Töpper C, et al. Protein binding characteristics and pharmacokinetics of ceftriaxone in intensive care unit patients. Br J Clin Pharmacol. 2015;80:525–533.
1. Wong G, Briscoe S, Adnan S, et al. Protein binding of β-lactam antibiotics in critically ill patients: can we successfully predict unbound concentrations? Antimicrob Agents Chemother. 2013;57:6165–6170.
1. Colman S, Stove V, De Waele JJ, et al. Measuring unbound versus total piperacillin concentrations in plasma of critically ill patients: methodological issues and relevance. Ther Drug Monit. 2019;41:325–330.
1. Rao Z, Dang ZL, Li B, et al. Determination of total and unbound meropenem, imipenem/cilastatin, and cefoperazone/sulbactam in human plasma: application for therapeutic drug monitoring in critically ill patients. Ther Drug Monit. 2020;42:578–587.